Colorectal cancer referrals during the COVID-19 pandemic: the utility of CT and faecal immunochemical testing
- PMID: 33793747
- PMCID: PMC7929281
- DOI: 10.1093/bjs/znaa140
Colorectal cancer referrals during the COVID-19 pandemic: the utility of CT and faecal immunochemical testing
References
-
- Maclean W, Limb C, Mackenzie P, Whyte MB, Benton SC, Rockall T. et al. Adoption of faecal immunochemical testing for two-week wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre. Colorectal Dis 2020; doi: 10.1111/codi.15408 [Epub ahead of print] - PubMed
-
- D’Souza N, Georgiou Delisle T, Chen M, Benton S, Abulafi M; NICE FIT Steering Group. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study. Gut 2020; doi: 10.1136/gutjnl-2020-321956 [Epub ahead of print] - PMC - PubMed
-
- ACPGBI Legacy Working Group. Legacy of COVID-19—the opportunity to enhance surgical services for patients with colorectal disease. Colorectal Dis 2020;22:1219–1228 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
